To achieve this goal, nucleases can target transcriptional repressors of γ-globin genes (HBG1/2) like B-cell lymphoma/leukemia 11A (BCL11a) or inhibitory regions in HBG1/2 promoters. This evidence concerns the gene HBG1 and B-cell non-Hodgkin lymphoma.